Therapeutic properties of Pleurotus species (oyster mushrooms) for atherosclerosis: A review

References

• Chang, S.T. World Production of Cultivated and Medicinal Mushrooms in 1997 with Emphasis on Lentinus Edodes (Berk.) Sing, China. Internationl Journal of Medicinal Mushroom 1999, 1, 291–300.
   Google Scholar
• St. Clair, R. Pathogenesis of Atherosclerosis. Cardiology in Review 1997, 5, 14–71.
   Google Scholar
• Landmesser, U.; Drexler, H. Antioxidant and Cardiovascular Disese. In General Concept about Oxidative Stress; Bourassa, M.G.; Tardif, J.; Eds.; New York, United States of America, 2006.
   Google Scholar
• Gaut, J.P.; Byun, J.; Tran, H.D. Myeloperoxidase Produces Nitrating Oxidants in Vivo. The Journal of Clinical Investigation 2002, 109, 1311–1319.
   PubMed Web of Science ®Google Scholar
• Claudio Borghi, G.G.; Taddei, S. Interactions Between Hypertension and Hypercholesterolemia: From Epidemiology to Therapeutic Implications. Current Hypertension Reviews 2008, 4, 1–7.
   Google Scholar
• Wilson, M.D.; Rudel, L.L. Review of Cholesterol Absorption with Emphasis on Dietary and Biliary Cholesterol. The Journal of Lipid Research 1994, 35, 943–955.
   PubMed Web of Science ®Google Scholar
• George, S.J.; Johnson, J. Atherosclerosis: Molecular and Cellular Mechanisms. John Wiley & Sons: New Jersey, United States of America, 2010.
   Google Scholar
• Bourassa, M.G.; Tardif, J.-C. Antioxidants and Cardiovascular Disease. Springer: New York, United States of America, 2006.
   Google Scholar
• Thilakarathna, S.H.; Rupasinghe, H.V. Anti-Atherosclerotic Effects of Fruit Bioactive Compounds: A Review of Current Scientific Evidence. Canadian Journal of Plant Science 2012, 92(3), 407–419.
   Web of Science ®Google Scholar
• Bonomini, F.; Tengattini, S.; Fabiano, A.; Bianchi, R.; Rezzani, R. Atherosclerosis and Oxidative Stress, 2008.
   Google Scholar
• Tsimikas, S. Antioxidant and Cardiovascular Disease. In Lipoprotein and Oxidation; Bourassa, M.G.; Tardif, J.; Eds.; Springer: New York, United States of America, 2006, 23(3), 381–390.
   Google Scholar
• Napoli, C.; D’armiento, F.; Mancini, F.; Postiglione, A.; Witztum, J.; Palumbo, G.; Palinski, W. Fatty Streak Formation Occurs in Human Fetal Aortas and is Greatly Enhanced by Maternal Hypercholesterolemia. Intimal Accumulation of Low Density Lipoprotein and Its Oxidation Precede Monocyte Recruitment into Early Atherosclerotic Lesions. Journal of Clinical Investigation 1997, 100(11), 2680.
   Google Scholar
• Napoli, C.; Glass, C.K.; Witztum, J.L.; Deutsch, R.; D’Armiento, F.P.; Palinski, W. Influence of Maternal Hypercholesterolaemia During Pregnancy on Progression of Early Atherosclerotic Lesions in Childhood: Fate of Early Lesions in Children (FELIC) Study. The Lancet 1999, 354(9186), 1234–1241.
   PubMed Web of Science ®Google Scholar
• Cyrus, T.; Pratico, D.; Zhao, L. Absence of 12/15-lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E-Deficient Mice. Circulation 2001, 103, 2277–2282.
   PubMed Web of Science ®Google Scholar
• Bocan, T.M.; Rosebury, W.S.; Mueller, S.B. A Specific 15-Lipoxygenase Inhibitor Limits the Progression and Monocyte-Macrophage Enrichment of Hypercholesterolemia induced Atherosclerosis in the Rabbit. Atheroslerosis 1998, 136, 203–216.
   PubMed Web of Science ®Google Scholar
• Borghi, C.; Grassi, G.; Taddei, S. Interactions Between Hypertension and Hypercholesterolemia: From Epidemiology to Therapeutic Implications. Current Hypertension Reviews 2008, 4(1), 1–7.
   Google Scholar
• Nickenig, G.; Harrison, D.G. The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis, Part I: Oxidative Stress and Atherogenesis. Circulation 2002, 105, 393–396.
   PubMed Web of Science ®Google Scholar
• Falk, E. Pathogenesis of Atherosclerosis. Journal of the American College of Cardiology 2006, 47(8s1), C7–C12.
   PubMed Web of Science ®Google Scholar
• Imig, J.D. ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses EDHF Involvement. Hypertension 2004, 43(3), 533–535.
   PubMed Web of Science ®Google Scholar
• Tipnis, S.R.; Hooper, N.M.; Hyde, R.; Karran, E.; Christie, G.; Turner, A.J. A Human Homolog of Angiotensin-Converting Enzyme: Cloning and Functional Expression as a Captopril-Insensitive Carboxypeptidase. The Journal of Biological Chemistry 2000, 275, 33238–33243.
   PubMed Web of Science ®Google Scholar
• Grote, K.; Drexler, H.; Schieffer, B. Renin-Angiotensin System and Atherosclerosis. Nephrology Dialysis Transplant 2004, 19, 770–773.
   PubMed Web of Science ®Google Scholar
• Schmaier, A.H. The Plasma Kallikrein-Kinin System Counterbalances The Renin-Angiotensin System. Review. Journal of Clinical Investigation 2002, 109, 1007–1009.
   PubMed Web of Science ®Google Scholar
• Durrington, P. Dyslipidaemia. The Lancet 2003, 362(9385), 717–731.
   PubMed Web of Science ®Google Scholar
• Barter, P. HDL-C: Role as a Risk Modifier. Atherosclerosis Supplements 2011, 12(3), 267–270. DOI:10.1016/s1567-5688(11)70885-6
   PubMed Web of Science ®Google Scholar
• Badimon, L.; Vilahur, G. LDL-Cholesterol Versus HDL-Cholesterol in the Atherosclerotic Plaque: Inflammatory Resolution Versus Thrombotic Chaos. Annals of the New York Academy of Sciences 2012, 1254, 18–32. DOI:10.1111/j.1749-6632.2012.06480.x
   PubMed Web of Science ®Google Scholar
• Tani, S.; Nagao, K.; Hirayama, A. HMG-Coa Reductase Inhibitor (Statin) Therapy and Coronary Atherosclerosis in Japanese Subjects: Role of High-Density Lipoprotein Cholesterol. American Journal of Cardiovascular Drugs: Drugs, Devices, and Other Interventions 2011, 11(6), 411–417. DOI:10.2165/11594620-000000000-00000
   PubMed Web of Science ®Google Scholar
• Navab, M.; Ananthramaiah, G.; Reddy, S.T.; Van Lenten, B.J.; Ansell, B.J.; Fonarow, G.C.; Vahabzadeh, K.; Hama, S.; Hough, G.; Kamranpour, N. Thematic Review Series: The Pathogenesis of Atherosclerosis the Oxidation Hypothesis of Atherogenesis: The Role of Oxidized Phospholipids and HDL. Journal of Lipid Research 2004, 45(6), 993–1007.
   PubMed Web of Science ®Google Scholar
• Barterm, P.J.; Nicholls, S.; Rye, K.-A.; Anantharamaiah, G.; Navab, M.; Fogelman, A.M. Antiinflammatory Properties of HDL. Circulation Research 2004, 95(8), 764–772.
   PubMed Web of Science ®Google Scholar
• Mineo, C.; Deguchi, H.; Griffin, J.H.; Shaul, P.W. Endothelial and Antithrombotic Actions of HDL. Circulation Research 2006, 98(11), 1352–1364.
   PubMed Web of Science ®Google Scholar
• Tso, C.; Martinic, G.; Fan, W.-H.; Rogers, C.; Rye, K.-A.; Barter, P.J. High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26(5), 1144–1149.
   PubMed Web of Science ®Google Scholar
• Bonifacino, J.S.; Lippincott-Schwartz, J. Degradation of Proteins within the Endoplasmic Reticulum. Current Opinion in Cell Biology 1991, 3(4), 592–600.
   PubMedGoogle Scholar
• Roitelman, J.; Olender, E.H.; Bar-Nun, S.; Dunn, W.A.; Simoni, R.D. Immunological Evidence for Eight Spans in the Membrane Domain of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase: Implications for Enzyme Degradation in the Endoplasmic Reticulum. The Journal of Cell Biology 1992, 117(5), 959–973.
   PubMed Web of Science ®Google Scholar
• Goldstein, J.L.; Brown, M.S. Regulation of the Mevalonate Pathway. Nature 1990, 343, 425–430.
   PubMed Web of Science ®Google Scholar
• Rallidis, L.S.; Fountoulaki, K.; Anastasiou-Nana, M. Managing the Underestimated Risk of Statin-Associated Myopathy. International Journal of Cardiology 2012, 159(3), 169–176.
   PubMed Web of Science ®Google Scholar
• Boa, E.R. Wild Edible Fungi: A Global Overview of Their Use and Importance to People. Food & Agriculture Org 2004, 17.
   Google Scholar
• Mizuno, T. The Extraction and Development of Antitumor-Active Polysaccharides from Medicinal Mushrooms in Japan (Review). International Journal of Medicinal Mushrooms 1999, 1(1) , 9–29.
   Google Scholar
• Manzi, P.; Gambelli, L.; Marconi, S.; Vivanti, V.; Pizzoferrato, L. Nutrients in Edible Mushrooms: An Inter-Species Comparative Study. Food Chemistry 1999, 65(4), 477–482. DOI:http://Dx.Doi.Org/10.1016/S0308-8146(98)00212-X
   Web of Science ®Google Scholar
• Lavi, I.; Friesem, D.; Geresh, S.; Hadar, Y.; Schwartz, B. An Aqueous Polysaccharide Extract from the Edible Mushroom Pleurotus Ostreatus Induces Anti-Proliferative and Pro-Apoptotic Effects on HT-29 Colon Cancer Cells. Cancer Letters 2006, 244(1), 61–70. DOI:10.1016/J.Canlet.2005.12.007
   PubMed Web of Science ®Google Scholar
• Lau, C.-C.; Abdullah, N.; Shuib, A.S.; Aminudin, N. Proteomic Analysis of Antihypertensive Proteins in Edible Mushrooms. Journal of Agricultural Food Chemistry 2012, 60(50), 12341–12348. DOI:10.1021/Jf3042159
   PubMed Web of Science ®Google Scholar
• Gil-Ramirez, A.; Cristina, C.; Palanisamy, M.; Reglero, G.; Perez, M. Edible Mushrooms as Potential Sources of New Hypocholesterolemic Compounds. Proceedings of the 7th International Conference on Mushroom Biology and Mushroom Products (ICMBMP7), 2011; 110–119 pp.
   Google Scholar
• Abdullah, N.; Ismail, S.M.; Aminudin, N.; Shuib, A.S.; Lau, B.F. (2012) Evaluation of Selected Culinary-Medicinal Mushrooms for Antioxidant and ACE Inhibitory Activities. Evid-Based Compl Alt 2012, 2012 (2012),1–12. DOI:10.1155/2012/464238
   Web of Science ®Google Scholar
• Mori, K.; Kobayashi, C.; Tomita, T.; Inatomi, S.; Ikeda, M. Antiatherosclerotic Effect of The Edible Mushrooms Pleurotus Eryngii (Eringi), Grifola Frondosa (Maitake), and Hypsizygus Marmoreus (Bunashimeji) in Apolipoprotein E-Deficient Mice. Nutrition Research 2008, 28(5), 335–342. DOI:10.1016/J.Nutres.2008.03.010
   PubMed Web of Science ®Google Scholar
• Ro, H.-S.; Kim, S.S.; Ryu, J.S.; Jeon, C.-O.; Lee, T.S.; Lee, H.-S. Comparative Studies on The Diversity of the Edible Mushroom Pleurotus Eryngii: ITS Sequence Analysis, RAPD Fingerprinting, and Physiological Characteristics. Mycological Research 2007, 111(6), 710–715.
   PubMed Web of Science ®Google Scholar
• Yildiz, A.; Karakaplan, M.; Aydin, F. Studies on Pleurotus Ostreatus (Jacq. Ex Fr.) Kum. Var. Salignus (Pers. Ex Fr.) Konr. Et Maubl.: Cultivation, Proximate Composition, Organic and Mineral Composition of Carpophores. Food Chemistry 1998, 61(1), 127–130.
   Web of Science ®Google Scholar
• Yildiz, S.; Yildiz, Ü.C.; Gezer, E.D.; Temiz, A. Some Lignocellulosic Wastes Used as Raw Material in Cultivation of the Pleurotus Ostreatus Culture Mushroom. Process Biochemistry 2002, 38(3), 301–306.
   Web of Science ®Google Scholar
• Ragunathan, R.; Gurusamy, R.; Palaniswamy, M.; Swaminathan, K. Cultivation of Pleurotus spp. on Various Agro-Residues. Food Chemistry 1996, 55(2), 139–144.
   Web of Science ®Google Scholar
• Gregori, A.; Švagelj, M.; Pohleven, J. Cultivation Techniques and Medicinal Properties of Pleurotus spp. Food Technology and Biotechnology 2007, 45(3), 238–249.
   Web of Science ®Google Scholar
• Patel, Y.; Naraian, R.; Singh, V. Medicinal Properties of Pleurotus Species (Oyster Mushroom): A Review. World Journal of Fungal and Plant Biology 2012, 3(1), 1–12.
   Google Scholar
• Chang, S.; Buswell, J. Mushroom Nutriceuticals. World Journal of Microbiology and Biotechnology 1996, 12(5), 473–476.
   PubMed Web of Science ®Google Scholar
• Ajith, T.A.; Janardhanan, K.K. Indian Medicinal Mushrooms as a Source of Antioxidant and Antitumor Agents. Journal of Clinical Biochemistry and Nutrition 2007, 40(3), 157.
   PubMed Web of Science ®Google Scholar
• Wu, G.-H.; Hu, T.; Li, Z.-Y.; Huang, Z.-L.; Jiang, J.-G. In Vitro Antioxidant Activities of the Polysaccharides from Pleurotus tuber-regium (Fr.) Sing. Food Chemistry 2014, 148(0), 351–356. DOI:http://Dx.Doi.Org/10.1016/J.Foodchem.2013.10.029
   PubMed Web of Science ®Google Scholar
• Adebayo, E.A.; Oloke, J.K.; Ayandele, A.A.; Adegunlola, C.O. Phytochemical, Antioxidant and Antimicrobial Assay of Mushroom Metabolite from Pleurotus pulmonarius—LAU 09 (JF736658) Journal of Microbiology and Biotechnology Research 2012, 2(2), 366–374.
   Google Scholar
• Li, R.; Kwan, Y.; Sit, A.; Ho, E.; Man, R.; Vanhoutte, P.; Leung, G. Ergothioneine Shows Protective Effect on Endothelial Cells in Oxidative Stress. FASEB 2011, 23, 630–633.
   Google Scholar
• Li, R.W.; Yang, C.; Sit, A.S.; Kwan, Y.W.; Lee, S.M.; Hoi, M.P.; Chan, S.W.; Hausman, M.; Vanhoutte, P.M.; Leung, G.P. Uptake and Protective Effects of Ergothioneine in Human Endothelial Cells. The Journal of Pharmacology and Experimental Therapeutics 2014, 350(3), 691–700. DOI:10.1124/Jpet.114.214049
   PubMed Web of Science ®Google Scholar
• Paul, B.D.; Snyder, S.H. The Unusual Amino Acid L-Ergothioneine is a Physiologic Cytoprotectant. Cell Death Differ 2010, 17(7), 1134–1140.
   PubMed Web of Science ®Google Scholar
• Ey, J.; Schömig, E.; Taubert, D. Dietary Sources and Antioxidant Effects of Ergothioneine. Journal of Agricultural Food Chemistry 2007, 55(16), 6466–6474.
   PubMed Web of Science ®Google Scholar
• Halliwell, B.; Lee, C.Y. Using Isoprostanes as Biomarkers of Oxidative Stress: Some Rarely Considered Issues. Antioxidants & Redox Signaling 2010, 13(2), 145–156. DOI:10.1089/Ars.2009.2934
   PubMed Web of Science ®Google Scholar
• Gruber, J.; Tang, S.Y.; Jenner, A.M.; Mudway, I.; Blomberg, A.; Behndig, A.; Kasiman, K.; Lee, C.Y.; Seet, R.C.; Zhang, W.; Chen, C.; Kelly, F.J.; Halliwell, B. Allantoin in Human Plasma, Serum, and Nasal-Lining Fluids Aas A Biomarker of Oxidative Stress: Avoiding Artifacts and Establishing Real in Vivo Concentrations. Antioxidants & Redox Signaling 2009, 11(8), 1767–1776. DOI:10.1089/Ars.2008.2364
   Google Scholar
• Seet, R.C.; Lee, C.Y.; Chan, B.P.; Sharma, V.K.; Teoh, H.L.; Venketasubramanian, N.; Lim, E.C.; Chong, W.L.; Looi, W.F.; Huang, S.H.; Ong, B.K.; Halliwell, B. Oxidative Damage in Ischemic Stroke Revealed Using Multiple Biomarkers. Stroke; A Journal of Cerebral Circulation 2011, 42(8), 2326–2329. DOI:10.1161/Strokeaha.111.618835
   PubMed Web of Science ®Google Scholar
• Cheah, I.K.; Halliwell, B. Ergothioneine; Antioxidant Potential, Physiological Function and Role in Disease. Biochimica et Biophysica Acta 2012, 1822(5), 784–793. DOI:10.1016/J.Bbadis.2011.09.017
   PubMed Web of Science ®Google Scholar
• Jang, J.-H.; Jeong, S.-C.; Kim, J.-H.; Lee, Y.-H.; Ju, Y.-C.; Lee, J.-S. Characterisation of a New Antihypertensive Angiotensin I-Converting Enzyme Inhibitory Peptide from Pleurotus Cornucopiae. Food Chemistry 2011, 127, 412–418.
   PubMed Web of Science ®Google Scholar
• Hagiwara, S.Y.; Takahashi, M.; Shen, Y.; Kaihou, S.; Tomiyama, T.; Yazawa, M.; Tamai, Y.; Sin, Y.; Kazusaka, A.; Terazawa, M. A Phytochemical in the Edible Tamogi-Take Mushroom (Pleurotus cornucopiae), D-Mannitol, Inhibits ACE Activity and Lowers the Blood Pressure of Spontaneously Hypertensive Rats. Bioscience, Biotechnology, and Biochemistry 2005, 69(8), 1603–1605. DOI:10.1271/Bbb.69.1603
   Google Scholar
• Zhou, X.; Gong, Z.; Su, Y.; Lin, J.; Tang, K. Cordyceps Fungi: Natural Products, Pharmacological Functions and Developmental Products. Journal of Pharmacy and Pharmacology 2009, 61(3), 279–291.
   PubMed Web of Science ®Google Scholar
• Xu, H.; Zheng, X.; Xu, C.; Zhao, Y.; Liu, F. The Protective Effect of Cordyceps Sinensis on Adriamycin-Induced Myocardial Damage. Acta Chin Med Pharmacol 2000, 28, 64–65.
   Google Scholar
• Miyazawa, N.; Okazaki, M.; Ohga, S. Antihypertensive Effect of Pleurotus Nebrodensis in Spontaneously Hypertensive Rats. Journal of Oleo Science 2008, 57(12), 675–681.
   PubMed Web of Science ®Google Scholar
• Wang, R.; Huang, Y.; Zhao, W. Pleurotus Extract and Use in Treating Hypertension. U.S. Patent: 20,030,161,842, 2003
   Google Scholar
• Alberts, A.; Chen, J.; Kuron, G.; Hunt, V.; Huff, J.; Hoffman, C.; Rothrock, J.; Lopez, M.; Joshua, H.; Harris, E. Mevinolin: A Highly Potent Competitive Inhibitor of Hydroxymethylglutaryl-Coenzyme A Reductase and a Cholesterol-Lowering Agent. Proceedings of the National Academy of Sciences 1980, 77( 7), 3957–3961.
   Google Scholar
• Tobert, J.A. Lovastatin and Beyond: The History of the HMG-Coa Reductase Inhibitors. Nature Reviews Drug Discovery 2003, 2(7), 517–526.
   PubMed Web of Science ®Google Scholar
• Gunde-Cimerman, N.; Cimerman, A. Pleurotus Fruiting Body Bodies Contain the Inhibitor of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Lovastatin. Experimental Mycology 1995, 19, 1–6.
   PubMedGoogle Scholar
• Gunde-Cimerman, N.; Plemenitas, A.; Cimerman, A. Pleurotus Fungi Produce Mevinolin, an Inhibitor of HMG Coa Reductase. FEMS Microbiology Letters 1993, 113(3), 333–337.
   PubMed Web of Science ®Google Scholar
• Alarcon, J.; Aguila, S.; Arancibia-Avila, P.; Fuentes, O.; Zamorano-Ponce, E.; Hernandez, M. Production and Purification of Statins from Pleurotus Ostreatus (Basidiomycetes) Strains. Zeitschrift Fur Naturforschung C 2003, 58(1/2), 62–64.
   PubMed Web of Science ®Google Scholar
• Dos Santos, L.F.; Zanatta, A.L.; Soccol, V.T.; Torres, M.F.; Bonatto, S.J.R.; Rubel, R.; Soccol, C.R. (2013) Hypolipidemic and Antiatherosclerotic Potential of Pleurotus ostreatus, Cultived By Submerged Fermentation in The High-Fat Diet Fed Rats. Biotechnology and Bioprocess Engineering 2013, 18(1),201–208.
   Web of Science ®Google Scholar
• Alam, N.; Amin, R.; Khan, A.; Ara, I.; Shim, M.J.; Lee, M.W.; Lee, U.Y.; Lee, T.S. Comparative Effects of Oyster Mushrooms on Lipid Profile, Liver and Kidney Function in Hypercholesterolemic Rats. Mycobiology 2009, 37, 37–42.
   PubMedGoogle Scholar
• Alam, N.; Yoon, K.N.; Lee, T.S.; Lee, U.Y. Hypolipidemic Activities of Dietary Pleurotus Ostreatus in Hypercholesterolemic Rats. Mycobiology 2011, 39(1), 45–51.
   PubMedGoogle Scholar
• Anandhi, R.; Annadurai, T.; Anitha, T.S.; Muralidharan, A.R.; Najmunnisha, K.; Nachiappan, V.; Thomas, P.A.; Geraldine, P. Antihypercholesterolemic and Antioxidative Effects of an Extract of the Oyster Mushroom, Pleurotus Ostreatus, and Its Major Constituent, Chrysin, in Triton WR-1339-Induced Hypercholesterolemic Rats. Journal of Physiology and Biochemistry 2013, 69(2), 313–323.
   PubMed Web of Science ®Google Scholar
• Jayakumar, T.; Thomas, P.; Geraldine, P. In-Vitro Antioxidant Activities of an Ethanolic Extract of the Oyster Mushroom, Pleurotus Ostreatus. Innovative Food Science & Emerging Technologies 2009, 10(2), 228–234.
   Web of Science ®Google Scholar
• Chen, J.; Yong, Y.; Xia, X.; Wang, Z.; Liang, Y.; Zhang, S.; Lu, L. The Excreted Polysaccharide of Pleurotus Eryngii Inhibits the Foam-Cell Formation via Down-Regulation of CD36. Carbohydrate Polymers 2014 , 114(4), 16–23.
   Web of Science ®Google Scholar
• Alam, N.; Yoon, K.N.; Lee, J.S.; Cho, H.J.; Shim, M.J.; Lee, T.S. Dietary Effect of Pleurotus Eryngii on Biochemical Function and Histology in Hypercholesterolemic Rats. Saudi Journal of Biological Sciences 2011, 18(4), 403–409.
   PubMed Web of Science ®Google Scholar
• Bajaj, M.; Vadhera, S.; Brar, A.; Soni, G. Role of Oyster Mushroom (Pleurotus Florida) as Hypocholesterolemic/Antiatherogenic Agent. Indian Journal of Experimental Biology 1997, 35(10), 1070–1075.
   PubMedGoogle Scholar
• Hu, S.H.; Liang, Z.C.; Chia, Y.C.; Lien, J.L.; Chen, K.S.; Lee, M.Y.; Wang, J.C. Antihyperlipidemic and Antioxidant Effects of Extracts from Pleurotus citrinopileatus. Journal of Agricultural Food Chemistry 2006, 54(6), 2103–2110.
   PubMed Web of Science ®Google Scholar
• Schneider, I.; Kressel, G.; Meyer, A.; Krings, U.; Berger, R.G.; Hahn, A. Lipid Lowering Effects of Oyster Mushroom (Pleurotus Ostreatus) in Humans. Journal of Functional Foods 2011, 3(1), 17–24. DOI:http://Dx.Doi.Org/10.1016/J.Jff.2010.11.004
   Web of Science ®Google Scholar
• Guillamón, E.; García-Lafuente, A.; Lozano, M.; Rostagno, M.A.; Villares, A.; Martínez, J.A. Edible Mushrooms: Role in the Prevention of Cardiovascular Diseases Filoterapia 2010, 81, 715–723.
   Google Scholar